FDAnews
www.fdanews.com/articles/84631-wyeth-pharmaceuticals-named-to-r-d-directions-top-10-pipeline-list-as-the-strongest-primary-care-pipeline

WYETH PHARMACEUTICALS NAMED TO R&D DIRECTIONS TOP 10 PIPELINE LIST AS 'THE STRONGEST PRIMARY-CARE PIPELINE'

February 16, 2006

Wyeth Pharmaceuticals, a division of Wyeth , today announced that the R&D Directions Annual Report of Top 10 Pharmaceutical Pipelines included the Wyeth pipeline as "The Strongest Primary-Care Pipeline." This is the second year in a row that Wyeth has been included in the list. In 2004, Wyeth was designated "The Pipeline to Watch."
Finanzen.net